Sensitivity to MPTP is not increased in Parkinson' s disease-associated mutant α-synuclein transgenic mice

Journal of Neurochemistry

Volumn 77, Issue 4, 2001, Pages 1181-1184

  Rathke Hartlieb, Silvia ^a   Kahle, Philipp J ^b   Neumann, Manuela ^b   Ozmen, Laurence ^c   Haid, Sibylle ^a   Okochi, Masayasu ^b   Haass, Christian ^b   Schulz, Jörg B ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d Department of Neurology ^*  (Germany)

Author keywords

SYN; MPTP; Parkinson's disease; Transgenic mice; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; CATECHOLAMINE DERIVATIVE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; GENE MUTATION; HEREDITY; MOUSE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ALPHA-SYNUCLEIN; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, THY-1; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; HUMANS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURITES; NEURONS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PROMOTER REGIONS (GENETICS); SUBSTANTIA NIGRA; SYNUCLEINS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MUS MUSCULUS;

EID: 0035017068     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00366.x     Document Type: Article

References (20)

1. The first two authors contributed equally. Banerjee S. A., Roffler-Tarlov S., Szabo M., Frohman L. and Chikaraishi D. M. (1994) DNA regulatory sequences of the rat tyrosine hydroxylase gene direct correct catecholaminergic cell-type specificity of a human growth hormone reporter in the CNS of transgenic mice causing a dwarf phenotype. Mol. Brain Res. 24, 89-106.
2. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
3. Duda J. E., Lee V. M. and Trojanowski J. Q. (2000) Neuropathology of synuclein aggregates. J. Neurosci. Res. 61, 121-127.
4. Eberhardt O., von Coelln R., Kügler S., Lindenau J., Rathke-Hartlieb S., Gerhardt E., Haid S., Isenmann S., Gravel C., Srinivasan A., Weller M., Bähr M., Dichgans J. and Schulz J. B. (2000) Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J. Neurosci. 20, 9126-9134.
5. Feany M. B. and Bender W. W. (2000) A Drosophila model of Parkinson's disease. Nature 404, 394-398.
6. Forno L. S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259-272.
7. Giasson B. I., Uryu K., Trojanowski J. Q. and Lee V. M. (1999) Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274, 7619-7622.
8. Hartmann A., Hunot S., Michel P. P., Muriel M. P., Vyas S., Faucheux B. A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G. I., Agid Y. and Hirsch E. C. (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl Acad. Sci. USA 97, 2875-2880.
9. Kahle P. J., Neumann M., Ozmen L., Muller V., Jacobsen H., Schindzielorz A., Okochi M., Leimer U., van der Putten H., Probst A., Kremmer E., Kretzschmar H. A. and Haass C. (2000) Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J. Neurosci. 20, 6365-6373.
10. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A. and Mucke L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
11. Moechars D., Lorent K., De Strooper B., Dewachter I. and Van Leuven F. (1996) Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15, 1265-1274.
12. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L. and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 4565-4571.
13. Przedborski S., Chen Q., Vila M., Giasson B. I., Djaldatti R., Vukosavic S., Souza J. M., Jackson-Lewis V., Lee V. M.-Y. and Ischiropoulos H. (2001) Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem. 76, 637-640.
14. van der Putten H., Wiederhold K. H., Probst A., Barbieri S., Mistl C., Danner S., Kauffmann S., Hofele K., Spooren W. P., Ruegg M. A., Lin S., Caroni P., Sommer B., Tolnay M. and Bilbe G. (2000) Neuropathology in mice expressing human alpha-synuclein. J. Neurosci. 20, 6021-6029.
15. Schimmel J. J., Crews L., Roffler-Tarlov S. and Chikaraishi D. M. (1999) 4.5 kb of the rat tyrosine hydroxylase 5′ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors. Brain Res. Mol Brain Res. 74, 1-14.
16. Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E. and Beal M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP induced neurotoxicity in mice. J. Neurochem. 64, 936-939.
17. Tabrizi S. J., Orth M., Wilkinson J. M., Taanman J. W., Warner T. T., Cooper J. M. and Schapira A. H. (2000) Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity. Hum. Mol. Genet. 9, 2683-2689.
18. Tatton N. A. and Kish S. J. (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2.3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77, 1037-1048.
19. Vila M., Vukosavic S., Jackson-Lewis V., Neystat M., Jakowec M. and Przedborski S. (2000) Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem. 74, 721-729.
20. West M. J. (1999) Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 22, 51-61.